ONEAAV Trademark

Medicinal preparations for medical, pharmaceutical or veterinary use for the treatment of ophthalmic disorders, diseases of the central and peripheral nervous systems, hereditary disorders, genetic disorders and monogenic disorders; Chemical reagents for medical purposes; Chemical reagents for veterinary purposes; Biological reagents for medical purposes; Biological reagents for veterinary purposes; Biological preparations for use in cell cultures for medical purposes; Therapeutic biological preparations for use in targeted medical and clinical gene therapy, namely, for ophthalmic disorders, diseases of the central and peripheral nervous systems, hereditary disorders, genetic disorders and monogenic disorders; Pharmaceutical preparations for gene therapy for the treatment of ophthalmic disorders, diseases of the central and peripheral nervous systems, hereditary disorders, genetic disorders and monogenic disorders; Pharmaceutical preparations for cellular therapy for the treatment of ophthalmic disorders, diseases of the central and peripheral nervous systems, hereditary disorders, genetic disorders and monogenic disorders; Therapeutic biological preparations for use in the manufacture of pharmaceuticals

Research and development in the field of biotechnology and targeted gene therapy; Biological research in the field of targeted gene therapy systems and nucleic acid delivery systems; Pharmaceutical research and development; Biomedical research in the field of targeted gene therapy systems and nucleic acid delivery systems; Pharmaceutical research in the field of targeted gene therapy systems and nucleic acid delivery systems